Our CEO, Evan Unger is recognized by the journal "Radiology"MVTJan 25, 20230 min readUnger, Evan C.pdfDownload PDF • 180KB
Positive Clinical Trial Results with Lead Candidate, CardiSon (MVT-100)May 14th, 2025 Salt Lake City, Utah: Microvascular Therapeutics, Inc. (MVT), a biotechnology company, announced that it has completed...
Microvascular Therapeutics and Cordance Medical Announce Strategic PartnershipTucson, AZ & Mountain View, CA – Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased...
MVT and Soundjet Announce Collaboration Aiming to Bring New Treatment Options to Patients with Vascular ThrombosisMicrovascular Therapeutics, Inc. (MVT), and SoundJet Medical, Inc. (SoundJet) announce that they have entered into a strategic...
Comments